Follow
Verónica Moreno-Viedma
Title
Cited by
Cited by
Year
Osteopontin is a key player for local adipose tissue macrophage proliferation in obesity
M Tardelli, K Zeyda, V Moreno-Viedma, B Wanko, NG Grün, G Staffler, ...
Molecular metabolism 5 (11), 1131-1137, 2016
772016
Serum myostatin is upregulated in obesity and correlates with insulin resistance in humans
M Amor, BK Itariu, V Moreno-Viedma, M Keindl, A Jürets, G Prager, ...
Experimental and Clinical Endocrinology & Diabetes 127 (08), 550-556, 2019
742019
EPHA2 is a predictive biomarker of resistance and a potential therapeutic target for improving antiepidermal growth factor receptor therapy in colorectal cancer
G Martini, C Cardone, PP Vitiello, V Belli, S Napolitano, T Troiani, ...
Molecular Cancer Therapeutics 18 (4), 845-855, 2019
712019
Common dysregulated pathways in obese adipose tissue and atherosclerosis
V Moreno-Viedma, M Amor, A Sarabi, M Bilban, G Staffler, M Zeyda, ...
Cardiovascular diabetology 15, 1-12, 2016
502016
Osteopontin affects macrophage polarization promoting endocytic but not inflammatory properties
K Schuch, B Wanko, K Ambroz, A Castelo‐Rosa, V Moreno‐Viedma, ...
Obesity 24 (7), 1489-1498, 2016
402016
Vitamin A deficiency increases protein catabolism and induces urea cycle enzymes in rats
G Esteban-Pretel, MP Marín, F Cabezuelo, V Moreno, J Renau-Piqueras, ...
The Journal of nutrition 140 (4), 792-798, 2010
382010
Adiponectin regulates aquaglyceroporin expression in hepatic stellate cells altering their functional state
M Tardelli, V Moreno‐Viedma, M Zeyda, BK Itariu, FB Langer, G Prager, ...
Journal of gastroenterology and hepatology 32 (1), 253-260, 2017
352017
AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer
C Cardone, B Blauensteiner, V Moreno-Viedma, G Martini, V Simeon, ...
European Journal of Cancer 138, 1-10, 2020
302020
Differential sensitivity to adrenergic stimulation underlies the sexual dimorphism in the development of diabetes caused by Irs-2 deficiency
MJ Garcia-Barrado, MC Iglesias-Osma, V Moreno-Viedma, MFP Mansilla, ...
Biochemical pharmacology 81 (2), 279-288, 2011
252011
AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148M
M Tardelli, FV Bruschi, T Claudel, V Moreno-Viedma, E Halilbasic, ...
Scientific Reports 7 (1), 14661, 2017
212017
Adiponectin regulates AQP3 via PPARα in human hepatic stellate cells
M Tardelli, T Claudel, FV Bruschi, V Moreno-Viedma, M Trauner
Biochemical and Biophysical Research Communications 490 (1), 51-54, 2017
212017
Identification of matrix metalloproteinase-12 as a candidate molecule for prevention and treatment of cardiometabolic disease
M Amor, V Moreno-Viedma, A Sarabi, NG Grün, B Itariu, L Leitner, ...
Molecular Medicine 22, 487-496, 2016
152016
AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148M. Sci Rep 2017; 7: 14661
M Tardelli, FV Bruschi, T Claudel, V Moreno-Viedma, E Halilbasic, ...
5
AXL has a prognostic role in metastatic colorectal cancer (mCRC) and is a predictive biomarker of lack of efficacy of chemotherapy (CT)+ cetuximab in RAS wild type (WT …
C Cardone, B Blauensteiner, V Moreno-Viedma, MC Paul, G Martini, ...
Annals of Oncology 29, viii30, 2018
32018
A humanized osteopontin mouse model and its application in immunometabolic obesity studies
NG Grün, K Zeyda, V Moreno-Viedma, K Strohmeier, G Staffler, M Zeyda, ...
Translational Research 178, 63-73. e2, 2016
32016
Eph A2 expression is a predictive biomarker of poorer activity and efficacy of FOLFIRI+ cetuximab in RAS WT metastatic colorectal cancer (mCRC) patients (pts) in the CAPRI GOIM …
C Cardone, MC Paul, V Moreno-Viedma, G Martini, PP Vitiello, ...
Annals of Oncology 28, v576, 2017
22017
Peptide-based vaccination against OPN integrin binding sites does not improve cardio-metabolic disease in mice
NG Grün, K Strohmeier, V Moreno-Viedma, M Le Bras, C Landlinger, ...
Immunology letters 179, 85-94, 2016
22016
Inducible overexpression of a FAM3C/ILEI transgene has pleiotropic effects with shortened life span, liver fibrosis and anemia in mice
U Schmidt, B Uluca, I Vokic, B Malik, T Kolbe, C Lassnig, M Holcmann, ...
PloS one 18 (9), e0286256, 2023
12023
AXL expression predicts poor prognosis and lack of efficacy of anti-angiogenic and anti-epidermal growth factor receptor (EGFR) agents in patients (pts) with RAS wild type (WT …
C Cardone, B Blauensteiner, V Moreno-Viedma, PP Vitiello, G Martini, ...
Annals of Oncology 30, v37-v38, 2019
12019
Abstract A013: Role of EGFR in KRAS-mediated resistances in colorectal cancer.
E Adachi-Fernandez, V Moreno-Viedma, D Krauss, A Kirchmair, ...
Molecular Cancer Research 21 (5_Supplement), A013-A013, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20